These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 9795912)
1. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. Idilman R; De Maria N; Colantoni A; Van Thiel DH J Viral Hepat; 1998 Sep; 5(5):285-99. PubMed ID: 9795912 [TBL] [Abstract][Full Text] [Related]
2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Yu MW; Chen CJ Crit Rev Oncol Hematol; 1994 Oct; 17(2):71-91. PubMed ID: 7818788 [No Abstract] [Full Text] [Related]
5. Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy. Stroffolini T; Sagnelli E; Sagnelli C; Morisco F; Babudieri S; Furlan C; Pirisi M; Russello M; Smedile A; Pisaturo M; Almasio PL Infection; 2019 Oct; 47(5):805-810. PubMed ID: 31028627 [TBL] [Abstract][Full Text] [Related]
6. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690 [TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
8. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K; Pal NS; Arora SK Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884 [TBL] [Abstract][Full Text] [Related]
10. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Alencar RS; Gomes MM; Sitnik R; Pinho JR; Malta FM; Mello IM; Mello ES; Bacchella T; Machado MC; Alves VA; Carrilho FJ Braz J Med Biol Res; 2008 Mar; 41(3):235-40. PubMed ID: 18097499 [TBL] [Abstract][Full Text] [Related]
11. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
12. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711 [TBL] [Abstract][Full Text] [Related]
14. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma. Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Dondog B; Lise M; Dondov O; Baldandorj B; Franceschi S Eur J Cancer Prev; 2011 Jan; 20(1):33-9. PubMed ID: 21166097 [TBL] [Abstract][Full Text] [Related]
19. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. Robinson WS; Klote L; Aoki N J Med Virol; 1990 May; 31(1):18-32. PubMed ID: 2165515 [TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection. Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]